RecruitingNCT06082284

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

A Cross-sectional Study on the Positive Rate of Monoclonal Immunoglobulin (M Protein) in the Serum of Patients Seeking Medical Treatment in Tertiary Hospitals Based on a Highly Sensitive Serum M Protein Detection Method.


Sponsor

Zhujiang Hospital

Enrollment

10,000 participants

Start Date

Oct 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital;
  • Age: over 18 years old;
  • There are sufficient remaining serum samples and extensive informed consent has been signed.

Exclusion Criteria2

  • Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases;
  • Improper storage or repeated freeze-thaw of remaining serum samples.

Locations(1)

Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06082284


Related Trials